AnPac Bio-Medical Science Co., Ltd. (ANPC): Price and Financial Metrics
ANPC Price/Volume Stats
Current price | $4.37 | 52-week high | $11.99 |
Prev. close | $4.62 | 52-week low | $2.60 |
Day low | $4.25 | Volume | 35,700 |
Day high | $4.65 | Avg. volume | 26,396 |
50-day MA | $5.57 | Dividend yield | N/A |
200-day MA | $5.37 | Market Cap | 4.23M |
ANPC Stock Price Chart Interactive Chart >
AnPac Bio-Medical Science Co., Ltd. (ANPC) Company Bio
Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.
Latest ANPC News From Around the Web
Below are the latest news stories about ANPAC BIO-MEDICAL SCIENCE CO LTD that investors may wish to consider to help them evaluate ANPC as an investment opportunity.
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, today announced that its ticker symbol on the Nasdaq Stock Market ("Nasdaq") will change to "FRES" effective at the open of market trading on May 22, 2023 following the Compa |
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2022, with the U.S. Securities and Exchange |
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial ResultsFresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, announced today its unaudited financial results for the first quarter ended March 31, 2023. The Company's financial statements and related fina |
Fresh2 Reports Fiscal Year 2022 Annual Financial ResultsFresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd. ,"Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, announced today its annual financial results for the year ended December 31, 2022. |
Sidoti's Micro-Cap Virtual May ConferenceSidoti & Company, LLC has released the presentation schedule and weblinks for its two-day May Micro-cap Conference taking place Wednesday and Thursday, May 10-11, 2023. Presentation schedule is subject to change, please visit www.sidoti.com/events for the most updated version and webinar links. |
ANPC Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | -20.55% |
3-year | -96.11% |
5-year | N/A |
YTD | N/A |
2023 | 0.00% |
2022 | -80.82% |
2021 | -76.98% |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...